1479P Exploring Second-Line Therapy Outcome in Pancreatic Ductal Adenocarcinoma (PDAC) Patients with Germlinebrca1-2 Pathogenic Variants (Gbrca1-2Pv)G. Orsi,M. Milella,F. Nappo,M. Di Marco,M. Niger,S. Bozzarelli,M. G. Rodriquenz,S. Noventa,G. Giordano,I. G. Rapposelli,I. Bernardini,E. Vasile,M. Macchini,U. Peretti,M. M. Valente,C. Paratore,A. Spallanzani,M. Scartozzi,S. Cascinu,M. ReniAnnals of oncology（2021）引用 0|浏览30暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
